Sign In
Last checked at 
3 Jun 2024 15:25
3 June 2024
CRISM Therapeutics Corporation
(AIM:CRTX)
Director Dealing
CRISM Therapeutics Corporation ("CRISM" or the "Company") announces that it has been notified that Non-Executive Director, Gerald Beaney has purchased 25,000 ordinary shares of the Company at a price of 9.265 pence per share.
Following this purchase, Mr Beaney holds 25,000 ordinary shares, which represents approximately 0.08% of the Company's total issued share capital of 32,678,312.
Enquiries:
Company | Nomad and Broker | Financial PR |
CRISM Therapeutics Corporation | S.P. Angel Corporate Finance LLP | Buchanan |
Andrew Webb, CEO Chris McConville, CSO | Richard Morrison Adam Cowl |
Mark Court mark.court@buchanancomms.co.uk Jamie Hooper jamie.hooper@buchanancomms.co.uk |
via Buchanan | +44 (0) 20 3470 0470 | +44 (0) 20 7466 5000 |
Dealings by Persons Discharging Managerial Responsibilities
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||||||||
a)
| Name | Gerald Beaney | |||||||||
2
| Reason for the notification
| ||||||||||
a)
| Position/status | Non-Executive Director | |||||||||
b)
| Initial notification /Amendment | Initial Notification | |||||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||
a)
| Name | CRISM Therapeutics Corporation | |||||||||
b)
| LEI
| 213800XFW6MKVCHHPW88
| |||||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares with no par value | |||||||||
Identification code | ISIN: VGG042401262
| ||||||||||
b)
| Nature of the transaction
| Purchase of shares | |||||||||
c)
| Price(s) and volume(s) |
|
|
|
| ||||||
d)
| Aggregated information | ||||||||||
- Aggregated volume | 25,000 | ||||||||||
- Price | £2,316.25 | ||||||||||
e)
| Date of the transaction | 3 June 2024 | |||||||||
f)
| Place of the transaction | Outside a trading venue | |||||||||
Follow the stocks
